Dietary cholesterol, guidelines, and the limits of the evidence

For roughly forty years, U.S. dietary guidance advised limiting dietary cholesterol to under 300 mg per day — a ceiling that effectively warned against eating more than one egg a day. In the 2015–2020 Dietary Guidelines for Americans, that numerical limit was dropped. The advisory committee concluded that "cholesterol is not a nutrient of concern for overconsumption," reflecting evidence that dietary cholesterol has a weak and variable effect on blood cholesterol for most people. The guidelines still advised eating as little dietary cholesterol as practical, and the reversal was itself contested — a reminder that official guidance is a summary of contested evidence, not a fact.

Randomized controlled trials avoid confounding by assigning egg intake at random, but the trials that exist mostly measure **biomarkers** (blood LDL, HDL, total cholesterol) over weeks, not **hard outcomes** (heart attacks, deaths) over decades. They consistently show that adding eggs raises LDL relative to a no-egg diet — but raising a biomarker is not the same as causing disease, and the effect shrinks or vanishes when eggs replace other foods rather than being added on top. No long, large randomized trial has measured the effect of eggs on cardiovascular events directly, and for ethical and practical reasons one probably never will.

- How much should we trust observational associations that survive adjustment for known confounders, given that unknown confounders may remain? - Should we anchor on the biomarker trials (eggs raise LDL) or on the hard-outcome cohorts (mixed, mostly null for healthy people)? - How much should the answer be conditioned on the person — diabetic vs. non-diabetic, baseline diet, what the egg replaces? - And what is the right default under uncertainty for a cheap, nutrient-dense food with a small, contested risk signal?